srch

BPMC | Complete Blueprint Medicines Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

17.12.2018 · Blueprint Medicines Corporation Common Stock (BPMC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

03.12.2021 · Blueprint Medicines' (BPMC) Ayvakit, which has been approved to treat PDGFRA Exon 18 mutant gastrointestinal stromal tumors, has seen strong uptake since approval. However, stiff competition ...

Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and other vital information to help you with your stock trading and investing.

Real time Blueprint Medicines (BPMC) stock price quote, stock graph, news & analysis.

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

07.12.2021 · Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Nachricht | finanzen.net

Transformative science, targeted medicines. We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, ...

29.11.2021 · Blueprint Medicines anticipates the acquisition will close in Q4 of 2021. Related Link: Zai Lab Inks Back To Back Licensing Agreements For Cancer And Psychiatric Candidates .

We can readily understand why investors are attracted to unprofitable companies. For example, although... Simply Wall St.• ...

13.09.2020 · Is this a good biotech stock to buy right ... A lot of what big pharma wants. Blueprint Medicines is moving so quickly that Gavreto is actually …

9 equities research analysts have issued 1-year target prices for Blueprint Medicines' shares. Their forecasts range from $95.00 to $151.00. On average, they ...

03.12.2021 · Blueprint Medicines Corporation’s BPMC lead drug, Ayvakit (avapritinib), was approved by the FDA for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal ...

Market Cap6.492B · Shares Out58.84M · 10 Day Average Volume0.40M · Dividend- · Dividend Yield- · Beta0.72 · YTD % Change-2.41.

Get the latest Blueprint Medicines Corp (BPMC) real-time quote, historical performance, charts, and other financial information to help you make more ...

Blueprint Medicines Corporation has a strategic research collaboration with The University of Texas MD Anderson Cancer Center for accelerating development of ...

Blueprint Medicines Corporation Common Stock (BPMC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

19 rader · 01.12.2021 · 1 Unresectable or metastatic disease.; 2 CStone Pharmaceuticals has …